|
|
Box 3950 Laguna Hills, CA 92653-3950 USA phone: 949-643-9540 fax:949-625-9819
|
|
| Symbol |
BLGO.OB |
| Exchange |
OBB |
| Founded |
0 |
| Employees |
|
|
|
| www.biolargo.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Anti-infective agents into fabrics. |
 |
| Management |
| Dennis Calvert, President and Chief Executive Officer; Kenneth R. Code, Chief Technology Officer; Charley Dargan, Chief Financial Officer; Robert Szolomayer, Director; Jeffrey C. Wallace, Director |
| |
|
|
|
|
|
|
|
| Keywords |
| isan, cupridyne, cupridyne, the mini Isan,piezoelectric delivery |
|
|
|
| Description |
|
BioLargo Technologies is a technology-transfer company developing technologies that incorporate anti-infective agents into fabric-type absorbent webs. |
 |
| Technology / Differentiation |
| The BioLargo Technology can be incorporated at the manufacturing level of the substrate materials (for uses in absorbent material) which can then be used to make market ready products. The addition of the technology adds performance features to those products that can enhance the capabilities of the products and selling proposition. |
 |
 |
|
|
|
|
|
|